Supplementary Figure S1 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
Amanda L. Rinkenbaugh(University of North Carolina at Chapel Hill), Helen Piwnica‐Worms(Centre for Cancer Biology), Jeffrey T. Chang(Tufts University), Chunxiao Fu(The University of Texas MD Anderson Cancer Center), Gaiane M. Rauch(The University of Texas MD Anderson Cancer Center), Banu Arun(The University of Texas MD Anderson Cancer Center), Jason B. White(The University of Texas MD Anderson Cancer Center), Alastair M. Thompson(The University of Texas MD Anderson Cancer Center), Sabrina L. Jeter-Jones(The University of Texas MD Anderson Cancer Center), Stacy L. Moulder(The University of Texas MD Anderson Cancer Center), Clinton Yam(The University of Texas MD Anderson Cancer Center), Emily Powell(The University of Texas MD Anderson Cancer Center), Gloria V. Echeverria(Baylor College of Medicine), Rosanna Lau(The University of Texas MD Anderson Cancer Center), Faiza Baameur(The University of Texas MD Anderson Cancer Center), Petra den Hollander(The University of Texas MD Anderson Cancer Center), Elizabeth E. Ravenberg(Eli Lilly (United States)), Xiaomei Zhang(The University of Texas MD Anderson Cancer Center), Yuan Qi(The University of Texas MD Anderson Cancer Center), Jiansu Shao(The University of Texas MD Anderson Cancer Center), Shirong Cai(The University of Texas MD Anderson Cancer Center), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center), Rebekah Gould(The University of Texas MD Anderson Cancer Center), Lei Huo(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
|Journal of Clinical Oncology|2007|1.6k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991